Byfavo
Drug Anesthesiology
NDC 71390-011-11
General payments
$894,650
Research payments
$826,102
Through program year 2024, $894,650 in general payments and $826,102 in research payments were reported against Byfavo (Anesthesiology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $114,795 | 587 |
| 2023 | General | $131,738 | 1,214 |
| 2023 | Research | $202,847 | 10 |
| 2022 | General | $265,324 | 2,555 |
| 2022 | Research | $588,283 | 57 |
| 2021 | General | $382,792 | 4,175 |
| 2021 | Research | $34,972 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 36 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 36 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
8,531 general · 70 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.